EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $6,954,000 | +41.4% | 836,802 | +48.2% | 6.97% | +75.0% |
| Q1 2021 | $4,917,000 | -51.3% | 564,555 | -39.3% | 3.98% | -48.3% |
| Q4 2020 | $10,105,000 | -15.5% | 930,467 | -7.2% | 7.70% | -18.4% |
| Q3 2020 | $11,960,000 | -16.4% | 1,002,528 | +12.5% | 9.44% | -5.8% |
| Q2 2020 | $14,314,000 | +14.2% | 891,277 | -0.3% | 10.02% | -18.8% |
| Q1 2020 | $12,539,000 | -47.2% | 893,698 | -7.4% | 12.34% | -22.5% |
| Q4 2019 | $23,752,000 | – | 965,519 | – | 15.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |